Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection

By M. Cannon, D. Schmid, Terri B. Hyde. Reviews in Medical Virology, 2010

1,507 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta‐analysis (2019, background): “The results are consistent with a socio‐economic link with CMV that has been well established in multiple studies showing that, at any given age, CMV prevalence is higher in individuals of lower socio‐economic group.(21) It has also been reported that the children of individuals born in a developing”
The “Silent” Global Burden of Congenital Cytomegalovirus (2013, neutral): “They estimated that the costs of medical and educational care for the thousands of children with asymptomatic and symptomatic congenital infection in the United States amounted to $1.9 billion per year, whereas the investment needed to develop a CMV vaccine would be approximately $360 million.”